Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...
SANTA CLARA, CA, UNITED STATES, December 18, 2025 /EINPresswire.com/ -- Accesso Biotech Corporation today announced new financial and strategic support from the Gates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results